Antiarrhythmic Effect of Ranolazine in Combination with Class III Drugs in an Experimental Whole-Heart Model of Atrial Fibrillation
- 27 November 2013
- journal article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 31 (6), e63-e71
- https://doi.org/10.1111/1755-5922.12035
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparison of Effectiveness of Ranolazine Plus Amiodarone Versus Amiodarone Alone for Conversion of Recent-Onset Atrial FibrillationThe American Journal of Cardiology, 2012
- Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass GraftingThe American Journal of Cardiology, 2011
- Electrophysiologic basis for the antiarrhythmic actions of ranolazineHeart Rhythm, 2011
- Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelinesEP Europace, 2011
- Synergistic Effect of the Combination of Ranolazine and Dronedarone to Suppress Atrial FibrillationJournal of the American College of Cardiology, 2010
- Altered Na+Currents in Atrial Fibrillation: Effects of Ranolazine on Arrhythmias and Contractility in Human Atrial MyocardiumJournal of the American College of Cardiology, 2010
- Synergistic Electrophysiologic and Antiarrhythmic Effects of the Combination of Ranolazine and Chronic Amiodarone in Canine AtriaCirculation: Arrhythmia and Electrophysiology, 2010
- Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine HeartJournal of Cardiovascular Electrophysiology, 2009
- Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparationsHeart Rhythm, 2008
- Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationCirculation, 2007